Gemcitabine: all 1,576 studies that test it
Page 11 of 16. Open to participants first (193), then studies with results posted, then the rest; newest registration first within each.
- Adjuvant Gemcitabine and Cisplatin Followed by Chemoradiation for Resected Pancreatic CancerCompletedNCT01396681Phase 2
- Fixed Dose Rate Gemcitabine and Cisplatin Followed by Chemoradiation for Locally Advanced Pancreatic CancerCompletedNCT01396668Phase 2
- Efficacy and Safety of a Neoadjuvant Treatment in Pancreatic CancerCompletedNCT01389440Phase 2
- Panitumumab Plus Gemcitabine and Oxaliplatin (GEMOX)Versus GEMOX Alone to Treat Advanced Biliary Tract AdenocarcinomaCompletedNCT01389414Phase 2
- SOM 230 and Gemcitabine in Advanced Pancreatic CancerCompletedNCT01385956Phase 1
- New Treatment Option for Pancreatic CancerCompletedNCT01364805Phase 1
- A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or LymphomaCompletedNCT01359696Phase 1
- Customizing First Line Chemotherapy in Advanced Non-Small Cell Lung CancerTerminatedNCT01356368Phase 2
- Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid TumorsCompletedNCT01352962Phase 1
- Neoadjuvant Chemotherapy With Docetaxel and Gemcitabine in Locally Advanced Breast CancerStatus unknownNCT01352494Phase 2
- Study of CEP-9722 in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors or Mantle Cell LymphomaCompletedNCT01345357Phase 1
- Maintenance Gemcitabine in the Chinese Advanced Lung CancerStatus unknownNCT01336192Phase 4
- PiCCA Study (Panitumumab in Combination With Cisplatin/Gemcitabine)CompletedNCT01320254Phase 2
- Adjuvant Versus Neoadjuvant Plus Adjuvant Chemotherapy in Resectable Pancreatic CancerTerminatedNCT01314027Phase 3
- Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by SurgeryCompletedNCT01313377Phase 3
- Study Evaluating Two Loading Regimens of Sunitinib or Bevacizumab Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC)CompletedNCT01309633Phase 2
- Gemcitabine Hydrochloride, Rituximab, Oxaliplatin, and Lenalidomide in Treating Patients With Relapsed or Refractory, Aggressive Non-Hodgkin LymphomaStatus unknownNCT01307592Phase 2
- Safety and Efficacy Study of Gemcitabine-erlotinib Versus Gemcitabine-erlotinib-capecitabine in Patients With Metastatic Pancreatic CancerCompletedNCT01303029Phase 2
- Ganitumab and Gemcitabine Hydrochloride Followed by Radiation Therapy, Ganitumab, Capecitabine, and Maintenance Therapy in Treating Patients With Locally Advanced Cancer of the PancreasCompletedNCT01298401Phase 1
- Study of Gemcitabine and Abraxane to Treat Potentially Operable Pancreatic CancerCompletedNCT01298011Phase 2
- A Phase I Study of Adjuvant Chemotherapy With GC in Biliary Tract Cancer Undergoing Resection Without Major HepatectomyCompletedNCT01297998Phase 1
- Phase I Study of Gemcitabine or S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract CancerCompletedNCT01291615Phase 1
- Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Paclitaxel in Triple Negative Breast Cancer (TNBC)CompletedNCT01287624Phase 3
- Gemcitabine/Cisplatin/S-1(GCS) Combination Therapy for Patients With Advanced Biliary Tract CancerCompletedNCT01284413Phase 1/2
- Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung CancerTerminatedNCT01282333Phase 1
- Neoadjuvant FDR GX in Locally Advanced Pancreatic CancerCompletedNCT01268384Phase 2
- A Randomized Study of GEMOX With or Without Cetuximab in Locally Advanced and Metastatic BTCCompletedNCT01267344Phase 2
- HLA-A*0201 Restricted Peptide Vaccine Therapy With Gemcitabine With Gemcitabine in Patient Pancreatic Cancer (Phase1)Status unknownNCT01266720Phase 1
- Combination With Gemcitabine in Advanced Pancreatic CancerCompletedNCT01251640Phase 1/2
- Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From CholangiocarcinomaCompletedNCT01247337Phase 2
- ABC-04 a Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract CancerCompletedNCT01242605Phase 1
- Cisplatin, Gemcitabine Hydrochloride, and Sorafenib Tosylate in Treating Patients With Transitional Cell Cancer of the BladderStatus unknownNCT01222676Phase 2
- Cetuximab + Gemox in Biliary Tract CancerCompletedNCT01216345Phase 2
- A Study of the Safety and Efficacy of CNTO 888 in Combination With SoC (Standard of Care) Chemotherapy in Patients With Solid TumorsCompletedNCT01204996Phase 1
- Gem-TABS in Unresectable Pancreatic CarcinomaCompletedNCT01198821Phase 1
- Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian CancerCompletedNCT01196559Phase 2
- A Study of Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT01189929Phase 1
- A Study of RO5083945 in Combination With Chemotherapy Versus Chemotherapy Alone in Patients With Advanced or Recurrent Non-Small Cell Lung CancerCompletedNCT01185847Phase 2
- Safety of 24-hour Infusion of ON 01910.Na in Combination With Gemcitabine in Advanced Solid TumorsCompletedNCT01165905Phase 1
- Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic AdenocarcinomaCompletedNCT01161186Phase 1
- ABT-888 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid TumorsCompletedNCT01154426Phase 1
- Gamma-Secretase Inhibitor RO4929097 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid TumorsCompletedNCT01145456Phase 1
- Preoperative Chemotherapy With Paclitaxel, Gemcitabine, and Lapatinib (Tykerb®) (PGT)CompletedNCT01133912Phase 1
- A Study Evaluating IPI-926 in Combination With Gemcitabine in Patients With Metastatic Pancreatic CancerCompletedNCT01130142Phase 1/2
- Dose Escalation Study of Gemcitabine and ON 01910.Na in Solid TumorsCompletedNCT01125891Phase 1
- Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver TransplantationStatus unknownNCT01125020Not applicable
- Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced MalignanciesCompletedNCT01113476Phase 1
- Pemetrexed and Gemcitabine for Treatment Resistant Patients With Metastatic Colorectal Cancer and KRAS MutationsTerminatedNCT01109615Phase 2
- Bevacizumab, Chemotherapy and Valproic Acid in Advanced SarcomasCompletedNCT01106872Phase 1
- Liposome-Encapsulated Doxorubicin Citrate With or Without Gemcitabine Hydrochloride in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity CancerStatus unknownNCT01100372Phase 2
- MK0752 and Gemcitabine Hydrochloride in Treating Patients With Stage III and IV Pancreatic Cancer That Cannot Be Removed by SurgeryCompletedNCT01098344Phase 1
- AS703569 and Gemcitabine Combination in Advanced MalignanciesCompletedNCT01097512Phase 1
- Randomized Trial of Gemcitabine/Cisplatin Versus S-1/Cisplatin in Advanced Biliary CancerTerminatedNCT01096745Phase 2
- Calcitriol, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by SurgeryTerminatedNCT01093092Phase 1
- Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the UrotheliumCompletedNCT01090466Phase 1/2
- Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT)CompletedNCT01089088Phase 2
- Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC)CompletedNCT01082549Phase 3
- Adjuvant Cisplatin Plus Gemcitabine in Operable Cholangiocellular Carcinoma.CompletedNCT01073839Phase 1/2
- Phase Ib/II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and SunitinibCompletedNCT01070706Phase 1/2
- Neoadjuvant GTX With Chemoradiation for Pancreatic Cancer (Stage II/III)Status unknownNCT01065870Phase 2/3
- A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid TumorsCompletedNCT01063816Phase 1
- A Study of Locally Advanced Pancreatic CancerStatus unknownNCT01063192Phase 2
- HAI Abraxane With Gemcitabine and BevacizumabCompletedNCT01057264Phase 1
- A Research Trial of High Dose Vitamin C and Chemotherapy for Metastatic Pancreatic CancerCompletedNCT01049880Phase 1
- Gemcitabine and Oxaliplatin (Gem-Ox) Plus Glivec in Gemcitabine-refractory Pancreatic CancerCompletedNCT01048320Phase 1
- Safety Study of Adjuvant Gemcitabine Started One Week After Laparoscopic Distal Pancreatectomy for AdenocarcinomaWithdrawnNCT01045941Phase 2
- Study of SAR240550 (BSI-201) in Combination With Gemcitabine/Carboplatin, in Patients With Metastatic Triple Negative Breast CancerCompletedNCT01045304Phase 2
- A Study of Gemcitabine as an Adjuvant Treatment for Cholangiocarcinoma After Surgical ResectionCompletedNCT01043172Phase 2
- Gemcitabine, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by SurgeryCompletedNCT01032057Phase 2
- A Safety and Efficacy Study of RX-0201 Plus Gemcitabine in Metastatic Pancreatic CancerCompletedNCT01028495Phase 2
- Margin-Intense Combo Therapy in Pts w/Potentially Resectable Pancreatic CancerTerminatedNCT01025882Phase 1
- A Study Evaluating Gemcitabine Plus Bosutinib for Patients With Resected Pancreatic CancerTerminatedNCT01025570Phase 1
- A Study of the Effect of Gemcitabine With Fish Oil in Patients With Advanced Pancreatic CancerCompletedNCT01019382Phase 2
- Conatumumab, Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic CancerWithdrawnNCT01017822Phase 1/2
- Erlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic CancerCompletedNCT01010945Phase 1
- Pharmacogenomic Study for Providing Personalized Strategy to the Treatment of Non-small Cell Lung Cancer (NSCLC) IIIB/IVCompletedNCT01003964Phase 2
- A Study of REOLYSIN® in Combination With Gemcitabine in Patients With Advanced Pancreatic AdenocarcinomaCompletedNCT00998322Phase 2
- Cisplatin and RT With or Without Gemcitabine, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced NPCStatus unknownNCT00997906Phase 2/3
- Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary CancerCompletedNCT00987766Phase 1
- Gemcitabine Hydrochloride, Cyclophosphamide, Vincristine Sulfate, Prednisolone, and Rituximab in Treating Patients With Newly Diagnosed Diffuse Large B-Cell LymphomaCompletedNCT00971763Phase 2
- Study With Rituximab-Gemcitabine/Oxaliplatin in Relapsed Indolent LymphomaTerminatedNCT00954005Phase 1/2
- Trial of Simvastatin and Gemcitabine in Pancreatic Cancer PatientsCompletedNCT00944463Phase 2
- Sorafenib With or Without Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Liver CancerCompletedNCT00941967Phase 2
- Safety and Tolerability Study of AZD7762 in Combination With GemcitabineTerminatedNCT00937664Phase 1
- Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin LymphomaTerminatedNCT00920153Phase 3
- Gemcitabine (GFF) in Patients With Pancreatic CancerCompletedNCT00919282Phase 2
- Biweekly Gemcitabine and Docetaxel as First Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC) PatientsStatus unknownNCT00906061Phase 2
- Biweekly Gemcitabine and Docetaxel as First Line Treatment for Advanced Disease in Elderly Non-Small Cell Lung Cancer (NSCLC) PatientsStatus unknownNCT00905983Phase 2
- Safety and Efficacy Study of P276-00 in Combination With Gemcitabine in Patients With Advanced Pancreatic CancerCompletedNCT00898287Phase 1/2
- Safety Study of ABT-263 in Combination With Gemzar (Gemcitabine) in Subjects With Solid TumorsCompletedNCT00887757Phase 1
- Gemcitabine, Capecitabine, and Erlotinib in Treating Patients With Advanced Pancreatic CancerCompletedNCT00885066Phase 1
- Individualized Treatment Based on Epidermal Growth Factor Receptor Mutations and Level of BRCA1 Expression in Advanced AdenocarcinomaCompletedNCT00883480Not applicable
- Rituximab, Gemcitabine, and Vinorelbine in Treating Patients With Hodgkin Lymphoma That Has Relapsed or Not Responded to TreatmentWithdrawnNCT00881387Phase 2
- Gemcitabine and Carboplatin for Elderly Patient With Lung CancerCompletedNCT00881296Phase 2
- Intensity-Modulated Radiation Therapy and Gemcitabine in Treating Patients With Locally Advanced Pancreatic CancerTerminatedNCT00878657Phase 1
- GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by SurgeryActive, not recruitingNCT00878163Phase 1
- Study of Sorafenib and Gemcitabine in Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT00844688Phase 2
- Radiotherapy With Single-Agent Cisplatin or Combination Chemotherapy in Defined Poor-Prognostic Cervical CancerStatus unknownNCT00842660Phase 3
- Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerStatus unknownNCT00838656Phase 2
- Irinotecan, Gemcitabine, Chemotherapy for Biliary Tract CancerCompletedNCT00832689Phase 2